An Openâ??Label, Two Group Clinical Study to Evaluate the Efficacy and Safety of HRUP-122101in Acute Musculoskeletal Pain or Acute Sports Injury Pain Relief

Himalaya Wellness Company0 个研究点目标入组 104 人开始时间: 待定最近更新: 2023年3月6日

试验速览

暂无简介。

•Adults of either gender aged >=18 - <=65 years and children of either gender aged >=12 - <= 17 years.
•2. Subjects with acute musculoskeletal pain (Back ache, joints pain, neck pain, shoulder pain etc.), sprain, strains and/ or acute sports injury pain.
•3. Subjects willing to sign informed consent/assent form and follow with the schedule.
•4. Subjects who have not participated in similar kind of study in last 4 weeks. 5. Parents/ Guardians/ Caregivers of the children of aged >=12- <= 17 willing to sign written consent (as applicable) and follow the study procedure. Children also should be giving the written assent

•Subjects with chronic pain like arthritis, gout, ankylosing spondylitis.
•2. Subjects suffering from auto-immune disorders, spastic disorders, genetic disorders, and severe traumatic conditions.
•3. Any evidence or history of hypersensitivity to any of the components in the HRUP-122101.
•4. Any known skin disorder or presence of open wounds.
•5. Subjects who are taking any additional topical therapy or systemic NSAIDs.
•6. Clinical diagnosis of bruised, trauma, muscle damage.
•7. Subjects with raw wounds, sutures, fractures, and hematoma.
•8. Pregnant or lactating women/ women not willing to follow adequate standard contraceptive measures.

发起方